Diebold Nixdorf Incorporated ( DBD ) shares are trading higher on Wednesday after the company reported second-quarter results.

The company reported adjusted earnings per share of $1.16, beating the analyst consensus of $1.05. Quarterly revenues of $939.7 million (+1.9%) exceeded the street view of $913.47 million.

Diebold Nixdorf ( DBD ) reported a significant 47.1% year-over-year increase in non-GAAP operating profit, reaching $102.8 million, with an operating profit margin of 10.9%, up 330 basis points from the previous year.

The company’s net income was $14.8 million, and adjusted EBITDA saw a 40.9% year-over-year increase to $118.8 million.

“Given our strong year-to-date execution and outlook for the remainder of 2024, we are raising our full-year adjusted EBITDA guidance to a range of $435 million to $450 million. We are well positioned for future success and are focused on continuing our momentum into the second half of the year,” Octavio Marquez, Diebold Nixdorf ( DBD ) president and chief executive officer, said.

Also Read: US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A ‘Growth Scare’ And Not ‘Calamity’

“We are well positioned for future success and are focused on continuing our momentum into the second half of the year,” Marquez added.

Outlook: Diebold Nixdorf ( DBD ) sees flat revenue growth in FY24, compared with a prior view of low single-digit growth.

The revised revenue forecast incorporates continued strength in banking, offset by retail product market headwinds and a modest unfavorable impact from foreign currency exchange.

The company sees adjusted EBITDA of $435 million—$450 million, which is higher than its prior view of $410 million—$435 million.

Diebold Nixdorf ( DBD ) also announced the addition of Maura Markus and Colin Parris to its board of directors.

Price Action: DBD shares are trading higher by 12.6% to $41.71 at last check Wednesday.

Read Next:

Move Over Yen, Yuan Carry Trades Could Be Next Ticking Bomb, Warns Strategists: ‘But It’s Below The Danger Levels We Monitor’